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Summary:   
In Rome, Italy, COVID-19 pneumonia is characterized by constant presence of peripheral ground-
glass opacities, associated with multilobe and posterior involvement, bilateral distribution, and 
subsegmental vessel enlargement. 
 
Keys Results:  
1. In this prospective study of patients in Rome, Italy, the sensitivity, specificity, and accuracy of CT 
for COVID-19 were 97%, 56%, and 72%, respectively, using RT-PCR as standard of reference. 
2. On chest CT, ground-glass opacities (GGO) were present in 100% of patients with RT-PCR 
confirmed COVID-19.  93% of patients had multilobe and posterior lung involvement; 91% of 
patients had bilateral pneumonia.  
3.  On CT, subsegmental vascular enlargement (more than 3 mm diameter) in areas of lung opacity 
was observed in 89% of patients with confirmed COVID-19 pneumonia, with unclear etiology. 
 
Abbreviations: 
SARS-CoV-2: Severe Acute Respiratory Syndrome Coronavirus 2 
COVID-19: Coronavirus Disease 2019 
RT-PCR: reverse transcription polymerase chain reaction 
GGO: ground-glass opacities 
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Abstract   
Background 
The standard for diagnosis of SARS-CoV-2 virus is reverse transcription polymerase chain reaction 
(RT-PCR) test, but chest CT may play a complimentary role in the early detection of COVID-19 
pneumonia.  
Purpose 
To investigate CT features of patients with COVID-19  in Rome, Italy, and to compare the accuracy 
of CT with RT-PCR. 
Methods 
In this prospective study from March 4, 2020, until March 19, 2020, consecutive patients with 
suspected COVID-19 infection and respiratory symptoms were enrolled. Exclusion criteria were: 
chest CT with contrast medium performed for vascular indications, patients who refused chest CT 
or hospitalization, and severe CT motion artifact. All patients underwent RT-PCR and chest CT. 
Diagnostic performance of CT was calculated using RT-PCR as reference. Chest CT features were 
calculated in a subgroup of RT-PCR-positive and CT-positive patients. CT features of hospitalized 
patients and patient in home isolation were compared by using Pearson chi squared test.  
Results 
Our study population comprised 158 consecutive study participants (83 male and 75 female, mean 
age 57 y 17). Fever was observed in 97/158 (61%), cough in 88/158 (56%), dyspnea in 52/158 
(33%), lymphocytopenia in 95/158 (60%), increased C-reactive protein level  in 139/158 (88%), and 
elevated lactate dehydrogenase in 128/158 (81%) study participants. Sensitivity, specificity, and 
accuracy of CT were 97% (60/62)[95% IC, 88-99%], 56% (54/96)[95% IC,45-66%] and 72% 
(114/158)[95% IC 64-78%], respectively. In the subgroup of RT-PCR-positive and CT-positive 
patients, ground-glass opacities (GGO) were present in 58/58 (100%), multilobe and posterior 
involvement were both present in 54/58 (93%), bilateral pneumonia in 53/58 (91%), and 
subsegmental vessel enlargement (> 3 mm) in 52/58 (89%) of study participants. 
Conclusion 
The typical pattern of COVID-19 pneumonia in Rome, Italy, was peripherally ground-glass opacities 
with multilobe and posterior involvement, bilateral distribution, and subsegmental vessel 
enlargement (> 3 mm).  Chest CT sensitivity was high (97%) but with lower specificity (56%). 
 
 
In 
Pre
ss
Introduction 
A novel coronavirus, named SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 
2) was identified related to the new emerging viral pneumonia consequently named COVID-19 
(Coronavirus Disease 2019). In accordance to the guidelines (3), the reference standard for the 
diagnosis of SARS-CoV-2 infection is next-generation sequencing or real-time reverse transcription 
polymerase chain reaction (RT-PCR) methods applied to respiratory tract specimens. However, 
due to intrinsic limitations (i.e. collection and transportation of samples and diagnostic kit 
performance), sensitivity of RT-PCR at initial presentation ranges between 60% and 71% (4-7).   
As reported by Ai (5), in a cohort of 1014 patients in Wuhan China, the sensitivity, 
specificity and accuracy of chest CT in the detection of COVID-19 pneumonia were 97%, 25% and 
68% respectively using RT-PCR results as reference standard. Similar results were found in other 
studies, suggesting that CT imaging may be helpful in early detection of interstitial pneumonia in 
patients with high degree of suspicion for COVID-19 pneumonia (6, 8).  
Typical chest CT patterns of COVID-19 viral pneumonia include multifocal bilateral 
peripheral ground glass areas associated with sub-segmental patchy consolidations mostly sub-
pleural and predominantly involving lower lung lobes and posterior segments (8-14).  
The aim of this study was to investigate chest CT features of patients with COVID-19  in 
Rome, Italy, and to compare the diagnostic performance of chest CT with RT-PCR. 
 
 
Material and Methods 
Patient Population and Study Design 
 This prospective study was approved by our local institutional review board (IRB) and 
written informed consent was obtained from all study participants. In case of inability of the 
patients to provide informed consent, it was received from the relatives or the admitting 
physicians who requested CT examination. 
Consecutive patients admitted at the Emergency Department of Sant’Andrea Hospital, 
were enrolled from March 4, 2020, until March 19, 2020. Inclusion criteria were (a) patients with 
fever and respiratory symptoms, such as cough, and dyspnea; (b) patients with mild respiratory 
symptoms and close contact with a confirmed COVID-19 patient; (c) patients with a previously 
positive test result. 
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Exclusion criteria were (a) chest CT with contrast medium performed for vascular 
indication (ie, pulmonary embolism, aortic dissection, coronary syndrome) , (b) patients who 
refused chest CT or hospitalization, (c) severe motion artifact on chest CT.  
 
Clinical Data 
All patients underwent a prescreening questionnaire about COVID-19 symptoms in one of 
the six dedicated tents for COVID-19 located outside the Emergency Department collecting 
specific clinical information: fever, cough and dyspnea. Fever was defined with a temperature 
>37.5°C. Thereafter, specific blood tests (COVID-19 panel, internal disposition) and 
nasopharyngeal and oropharyngeal swabs were obtained for each patient. To confirm the 
positivity to SARS-COV2, real-time reverse transcriptase RT-PCR (Charitè, Berlin, Germany) was 
used (15). All patients received two nasopharyngeal and oropharyngeal swabs at a time interval of 
24 hours. Patients were considered negative after two consecutive negative RT-PCR results. 
Patient demographic characteristics, clinical signs and symptoms, and laboratory results were 
collected. Symptomatic patients (fever >37.5°C, cough and dyspnea) with positive RT-PCR and 
positive CT were hospitalized, whereas patients with positive RT-PCR but negative CT (see below) 
and/or mild symptoms (fever ≤37.5°C, no dyspnea) were discharged for home isolation per our 
hospital guidelines. Data about hospitalization or home isolation were also collected. 
 
CT Acquisition Technique 
As part of our hospital COVID-19 guidelines, after the RT-PCR swabs, all patients underwent 
chest CT to determine the presence or absence of viral pneumonia. All chest CT acquisitions were 
obtained with the patients in supine position during end-inspiration without contrast medium 
injection. Chest CT performed on a 128-slice CT (GE Revolution EVO 64 Slice CT Scanner, GE 
Medical Systems, Milwaukee, WI, USA) dedicated only to patients with COVID-19 . The following 
technical parameters were used: tube voltage: 120 kV; tube current modulation 100-250 mAs; 
spiral pitch factor: 0.98; collimation width: 0.625. Reconstructions were made with convolution 
kernel BONEPLUS at a slice thickness of 1.25 mm. Decontamination of the room consisted of  
surface disinfection with 62-71% ethanol or 01% sodium hypochlorite.  After each patient chest CT 
examination, passive air exchange was performed for 40-60 minutes.  
 
CT Image Analysis   
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DICOM data were transferred onto a PACS workstation (Centricity Universal Viewer v.6.0, 
GE Medical Systems, Milwaukee, WI, USA). Two radiologists in consensus with 15 and 25 years of 
thoracic imaging experience evaluated the images using a clinically available dedicated application 
(Thoracic VCAR v13.1, GE), defining patients as CT-positive when a diagnosis of viral pneumonia 
was reported. 
The following CT features were also recorded (16): (a) ground-glass opacities (GGO), (b) 
GGO pattern, (c) GGO location, (d) consolidation, (e) multilobe involvement, (f) bilateral 
distribution, (g) location of consolidation or GGO, (h) pulmonary nodules surrounded by GGO, (i) 
interlobular septal thickening, (j) air bronchogram, (k) halo sign, (l) presence of cavitation, (m) 
bronchial wall thickening, (n) bronchiectasis, (o) perilesional vessel diameter, (p) 
lymphadenopathy (defined as lymph node with short axis > 10mm), (q) pleural and (r) pericardial 
effusion. 
 
Statistical Analysis 
Statistical analysis was performed using SPSS version 21.0 (SPSS Inc. Chicago, IL). All 
continuous variables were expressed as medians and ranges and categorical variables as counts 
and percentages. The diagnostic performance of CT was evaluated with sensitivity, specificity, 
positive predictive value (PPV), negative predictive value (NPV) and diagnostic accuracy 
considering RT-PCR as the reference standard. CT findings for patients who required 
hospitalization versus home-isolation were compared by using the Pearson chi-squared test. P 
values of <0.05 were considered statistically significant. A 95% confidence interval was provided 
by the Wilson score method. 
 
 
Results 
Patient Population and Clinical Data 
Study population comprised 158 consecutive study participants (83 male and 75 female, 
mean age 5717 y, range 18-89).  Fever was observed in 97/158 patients (61%). Cough and 
dyspnea were present in 88/158 (56%) and 52/158 (33%) patients, respectively.  
Laboratory blood tests on admission showed lymphocytopenia (defined as lymphocyte 
count <1.1×109/L), with a lymphocyte count of 1.08  0.47 ×109/L in 95/158 cases (60%); increased 
(>0.50 mg/dL) C-reactive protein (CRP) levels (13.64  38.68 mg/dL) in 139/158 (88%) patients; 
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increased (> 220 U/L) lactate dehydrogenase (LDH) levels (339.50  124.15 U/L) in 128/158 (81%) 
patients. Full results are reported in Table 1. 
 
CT Diagnostic Performance 
Sixty-two/158 (39%) patients had positive RT-PCR and 102/158 (64%) patients had positive 
CT findings. Detailed results are reported in Table 2. Using RT-PCR as reference standard, 
sensitivity, specificity and accuracy of CT for COVID-19 pneumonia were  97% (60/62)[95% IC, 88-
99%], 56% (54/96)[95% IC,45-66%] and 72% (114/158)[95% IC 64-78%], respectively.  
 
CT Image Analysis   
 To understand the CT features of patients with COVID-19 pneumonia, a sub-analysis was 
performed considering only study participants with positive RT-PCR testing and chest CT findings.   
Of 158 study participants, 62 participants were RT-PCR-positive and among these, 60 participants 
were classified as CT-positive. Considering the exclusion of two study participants due to the 
presence of severe chest CT motion artifact, 58 study participants were evaluated in this sub-
analysis (Figure 1).  
GGO were present in 58/58 patients (100%), multilobe involvement ( 2 lobes) and 
posterior involvement were both present in 54/58 (93%) patients, 53/58 (91%) patients had 
bilateral pneumonia distribution, and peripheral GGO location was observed in 52/58 (89%).  
A simultaneous involvement of all five lobes was observed in 43/58 patients (74%). Right 
lower lobe was the most affected in 53/58 patients (93%), followed by left lower lobe and right 
upper lobe involved in 51/58 patients (both 91%). Regarding GGO, three patterns were observed 
in order of frequency as follows: Crazy paving in 23/58 patients (39%), rounded morphology in 
19/58 patients (32%) and linear opacities in 16/58 cases (27%).  
An enlarged subsegmental vessel, defined as vessel diameter > 3 mm, was observed in 
52/58 patients (89%) with mean vessel diameter of 3.9±0.6 mm. Consolidation was observed in 
42/58 patients (72%) including 32/58 (55%) with subsegmental involvement. Presence of 
lymphadenopathy was reported in 34/58 patients (59%). Less frequent findings are shown  in 
Table 3 and Table 4. Examples of chest CT findings are shown in Figures 2 and 3. 
Chest CT features were compared between patients who required hospitalization 
(inpatients, 49 patients) versus those patients who were referred for home isolation (outpatients, 
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9 patients).  There were no significant differences in chest CT findings between these groups 
(Figure 5, all findings p> 0.06).  
 
 
Discussion 
To date, the majority of results evaluating the use of chest CT for COVID-19 pneumonia 
were of patient populations in China.  We conducted a prospective study at our institution in 
Rome, Italy comparing chest CT to RT-PCR for COVID-19 infection.  Two RT-PCR tests within 24 
hours were used to confirm the presence or absence of COVID-19 infection.  In 158 study 
participants, the sensitivity and specificity of chest CT was 97% (60/62) [95% IC, 88-99%] and 56% 
(54/96) [95% IC,45-66%], respectively. Typical CT features of COVID-19 were ground glass opacities 
(58/58, 100%), multilobe (>2 lobes) and posterior involvement (both 54/58, 93%) and bilateral 
pneumonia distribution (53/58, 91%).  On CT, subsegmental vascular enlargement (more than 3 
mm diameter) in areas of lung opacity was observed in 89% of patients with confirmed COVID-19 
pneumonia.  There were no significant differences of chest CT features for individuals who with 
severe disease who were hospitalized versus those referred for mild disease referred for self-
isolation, although the study size was small for this comparison (49 vs. 9 patients, respectively).   
Our results are in accordance with the systematic review performed by Salehi et al (17) of 
919 patients despite some interesting differences: our population showed a higher prevalence of 
pulmonary consolidations (72% vs 31%), GGO peripheral distribution (89% vs 76%) and ground 
glass opacities (100% vs 88%), respectively.  Our population differs from that of Zhu et al. of 32 
patients, where GGO was found in only 47% of patients with COVID-19 (19). Recently, Chung et al 
analyzed a small population of 21 patients, showing a very low frequency of crazy paving pattern 
compared to our results (19% vs 39%, respectively) (18).  Mediastinal adenopathy was also much 
more frequent in our population (58%).  In general, the patients in our study were somewhat older 
(mean, 57 years) with more men (52%) described in prior reports.   
An interesting chest CT feature was the presence of enlarged subsegmental pulmonary 
vessels 89% of study participants. This finding was described by Albarello et al in two patients in 
Italy (20).   Bai et al described subsegmental vascular enlargement in 59% of the patients with 
COVID-19 pneumonia versus those with 22% of those with non-viral pneumonia.  (14). Ye  et al 
suggested vascular enlargement may be due to pro-inflammatory factors (16). Subsegmental 
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vascular enlargement could reflect the hyperemia induced by SARS-CoV-2 infection versus viral 
pulmonary infections such as SARS and MERS (21) (22, 23).  
The diagnostic performance of chest CT in this study was in accordance with recently 
published data. Using RT-PCR as reference, we report a high sensitivity of 97%, moderate 
specificity of 56% and accuracy of 72%.  This was similar to results from Ai  et al reporting a 
sensitivity of 97%, specificity of 25% and accuracy of 68% in patients from Wuhan China (5).  
Several limitations should be addressed.  In our setting, clinical and laboratory data were 
limited due to the urgency of the situation. Patient outcomes were not available at the time of this 
communication.  The size of our patient study was limited. 
In conclusion, typical pattern of COVID-19 pneumonia on chest CT in Rome, Italy was 
characterized by the consistent presence of peripheral ground glass opacities associated with 
multilobe and posterior involvement, bilateral distribution, and subsegmental vessel enlargement 
(>3 mm). 
 
Acknowledgments: The authors would like to thank Paolo Anibaldi, MD, Giuseppe Argento, MD, 
Daniela Sergi, MD, and Antonio Cremona, MD, for Clinical and CT data collection, and Mariarita 
Tarallo, MD, PhD, for manuscript editing. We would like also to acknowledge the entire 
Radiological Medical and Technical Staff of the Radiology Unit of Sant'Andrea Academic Hospital in 
Rome.  
In 
Pre
ss
 
References 
1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in 
Wuhan, China. Lancet 2020;395(10223):497-506. doi: 10.1016/s0140-6736(20)30183-5 
2. Novel Coronavirus (2019-nCoV) situation reports. 2020.  
3. Interim Guidance: Healthcare Professionals 2019-nCoV | CDC. 2020.  
4. Yang Y, Yang M, Shen C, et al. Evaluating the accuracy of different respiratory specimens in the 
laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. 2020. doi: 
10.1101/2020.02.11.20021493 
5. Ai T, Yang Z, Hou H, et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 
2019 (COVID-19) in China: A Report of 1014 Cases. Radiology 2020:200642. doi: 
10.1148/radiol.2020200642 
6. Fang Y, Zhang H, Xie J, et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. 
Radiology 2020:200432. doi: 10.1148/radiol.2020200432 
7. Kanne JP, Little BP, Chung JH, et al. Essentials for Radiologists on COVID-19: An Update-
Radiology Scientific Expert Panel. Radiology 2020:200527. doi: 10.1148/radiol.2020200527 
8. Ng M-Y, Lee EY, Yang J, et al. Imaging Profile of the COVID-19 Infection: Radiologic Findings and                    
Literature Review. https://doiorg/101148/ryct2020200034 2020. doi: 
https://doi.org/10.1148/ryct.2020200034 
9. Pan F, Ye T, Sun P, et al. Time Course of Lung Changes On Chest CT During Recovery From 2019 
Novel Coronavirus (COVID-19) Pneumonia. Radiology 2020:200370. doi: 
10.1148/radiol.2020200370 
10. Chung M, Bernheim A, Mei X, et al. CT Imaging Features of 2019 Novel Coronavirus (2019-
nCoV). Radiology 2020:200230. doi: 10.1148/radiol.2020200230 
11. Song F, Shi N, Shan F, et al. Emerging Coronavirus 2019-nCoV Pneumonia. Radiology 
2020:200274. doi: 10.1148/radiol.2020200274 
12. Pan Y, Guan H, Zhou S, et al. Initial CT findings and temporal changes in patients with the novel 
coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol 2020. doi: 
10.1007/s00330-020-06731-x 
13. Bernheim A, Mei X, Huang M, et al. Chest CT Findings in Coronavirus Disease-19 (COVID-19): 
Relationship to Duration of Infection. Radiology 2020:200463. doi: 10.1148/radiol.2020200463 
In 
Pre
ss
14. Bai HX, Hsieh B, Xiong Z, et al. Performance of radiologists in differentiating COVID-19 from 
viral pneumonia on chest CT. Radiology 2020:200823. doi: 10.1148/radiol.2020200823 
15. Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-
time RT-PCR. Euro Surveill 2020;25(3). doi: 10.2807/1560-7917.Es.2020.25.3.2000045 
16. Ye Z, Zhang Y, Wang Y, et al. Chest CT manifestations of new coronavirus disease 2019 (COVID-
19): a pictorial review. Eur Radiol 2020. doi: 10.1007/s00330-020-06801-0 
17. Salehi S, Abedi A, Balakrishnan S, et al. Coronavirus Disease 2019 (COVID-19): A Systematic 
Review of Imaging Findings in 919 Patients. AJR Am J Roentgenol 2020:1-7. doi: 
10.2214/ajr.20.23034 
18. Chung M, Bernheim A, Mei X, et al. CT Imaging Features of 2019 Novel Coronavirus (2019-
nCoV). Radiology 2020;295(1):202-207. doi: 10.1148/radiol.2020200230 
19. Zhu W, Xie K, Lu H, et al. Initial clinical features of suspected coronavirus disease 2019 in two 
emergency departments outside of Hubei, China. J Med Virol 2020. doi: 10.1002/jmv.25763 
20. Albarello F, Pianura E, Di Stefano F, et al. 2019-novel Coronavirus severe adult respiratory 
distress syndrome in two cases in Italy: An uncommon radiological presentation. Int J Infect Dis 
2020;93:192-197. doi: 10.1016/j.ijid.2020.02.043 
21. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for 
the SARS coronavirus. Nature 2003;426(6965):450-454. doi: 10.1038/nature02145 
22. Nicolaou S, Al-Nakshabandi NA, Muller NL. SARS: imaging of severe acute respiratory 
syndrome. AJR Am J Roentgenol 2003;180(5):1247-1249. doi: 10.2214/ajr.180.5.1801247 
23. Ooi GC, Khong PL, Muller NL, et al. Severe acute respiratory syndrome: temporal lung changes 
at thin-section CT in 30 patients. Radiology 2004;230(3):836-844. doi: 10.1148/radiol.2303030853 
 
  
In 
Pre
ss
 
Figure 1: Flow chart of the study.  
 
 
 
 
Figure 2: Axial and coronal thin-section unenhanced CT scan of 65-year-old man with unknown 
exposure history who presented with fever and cough. (a) Chest CT shows diffuse bilateral 
confluent and predominantly linear ground-glass opacities with a pronounced peripheral 
distribution and consolidation with air bronchogram (black arrow). (b) Coronal thin-section 
unenhanced CT scan shows diffuse bronchiectasis of both lower lobes (white arrows). 
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ss Figure 3: Axial and coronal thin-section unenhanced CT scan of 55-year-old man with history of recent travel to Milan who presented with fever and dyspnea. (a) Scan shows bilateral ground-glass opacities with rounded morphology (white arrow) in both upper and lower lobes, and interlobular/intralobular septal thickening (crazy paving).   (b) Scan shows predominantly apical ground-glass opacities with tubular size increase of 
segmental and subsegmental vessels (black arrow). 
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Tables 
Table 1: Clinical Data 
 Number of 
patients     
(n=158) 
% 
Patient demographics 
Mean age        5717 y 
Years (range) 18-89  
Total patients 158 100 
Male 83 52 
Female 75 47 
Result of RT-PCR assay   
Positive 62 39 
Negative 96 61 
Signs 
Fever (>37.5°C) 97 61 
Cough 88 56 
Dyspnea 52 33 
Laboratory test 
C-reactive protein (mg/L; normal range 0.00-0.50) 
Increased 139 88 
Normal 19 12 
Lactic Acid Dehydrogenase (U/L; range 125-220) 
Increased 128 81 
Normal 30 19 
Lymphocytes (×103/mm3, normal range 1.5–3.0) 
Increased 13 8 
Decreased 95 60 
Normal 50 32 
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Table 2: Diagnostic Performance of chest CT for COVID-19 infection with RT-PCR as the standard 
of reference 
 
 TP TN FP FN Sensitivity Specificity PPV NPV Accuracy 
Number 60 54 42 2 60/62 54/96 60/102 54/56 114/158 
Percentage     97% 56% 59% 96% 72% 
95% CI     88-99% 45-66% 53-64% 87-99% 64-78% 
 
 
 
CI confidence interval;  TP true positive, TN true negative, FP false positive, FN false negative, PPV positive predictive 
value, NPV negative predictive value. 
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Table 3: CT feature in patients with RT-PCR confirmed COVID-19 infection 
CT Features Analysis Patients (N=58) % (95% CI) 
Ground Glass Opacity (GGO) 58 100%  
Multilobe involvement ( 2 lobes) 54 93% (86-99) 
Bilateral distribution 53 91% (83-98) 
Posterior Involvement 54 93% (86-99) 
GGO location (peripheral) 52 89% (81-97) 
Subsegmental vessel enlargement (> 3 mm) 52 (3.9±0.6 mm) 89% (81-97) 
Consolidation 42 72% (60-83) 
Subsegmental 32 55% (42-67) 
Segmental 10 17%  (7-26) 
Lymphadenopathy 34 58% (45-70) 
Bronchiectasis 24 41% (28-53) 
Air Bronchogram 21 36% (26-45) 
Pulmonary nodules surrounded by GGO  10 17% (7-26) 
Interlobular Septal thickening 8 13% (4-21) 
Halo sign 7 12% (3-20) 
Pericardial Effusion 3 5% (0-10) 
Pleural effusion 2 3% (0-7) 
Bronchial wall thickening 1 1%  (0-3) 
Cavitation 0 0% 
CI confidence intervals 
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Table 4: CT feature in patients with RT-PCR confirmed COVID-19 infection 
CT Features sub-analysis Patients (n = 58) 
Number of lobes involved   % (95% CI) 
0 0  0% (NA) 
1 4  6% (0-12) 
2 2  3% (0-7) 
3 3  5% (0-10) 
4 6  10% (2-17) 
5 43  74% (62-85) 
Frequency of lobe involvement 
Right upper lobe 53  91% (83-98) 
Right middle lobe 48  82% (72-91) 
Right lower lobe 54 93% (86-99) 
Left upper lobe 49 84% (74-93) 
Left lower lobe 53 91% (83-98) 
GGO pattern 
Crazy Paving 23 39% (26-51) 
Rounded morphology 19 32% (19-44) 
Linear opacities 16 27% (15-38)  
CI confidence interval 
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Table 5: Comparison of chest CT features in patients hospitalized for COVID-19 pneumonia 
versus those referred home for self-isolation (mild disease) 
 
 
 
 
 
 
 
 
 
 
 
 
CT Features Inpatients Outpatients P value n = 49 % (95% CI) (n = 9) % (95% CI) 
Ground Glass Opacity 
(GGO) 49 100% 9 100% n.a. 
Multilobe involvement  
( 2 lobes) 46 93% (85-100) 8 88% (66-100) 0.58 
Bilateral distribution 46 93% (85-100) 7 77% (49-100) 0.11 
Posterior Involvement 46 93% (85-100) 8 88% (66-100) 0.58 
GGO location 
(peripheral) 45 91% (82-99) 7 77% (49-100) 0.20 
Subsegmental vessel 
enlargement (< 3 mm) 43 87% (77-96) 9 100% 0.66 
Consolidation 37 75% (62-87) 5 55% (22-87) 0.21 
Lymphadenopathy 22 44% (30-57) 1 11% (0-31) 0.06 
